Publications by authors named "Amna Roheel"

Various conventional treatments including endocrine therapy, radiotherapy, surgery, and chemotherapy have been used for several decades to treat breast cancer; however, these therapies exhibit various life-threatening and debilitating adverse effects in patients. Additionally, combination therapies are required for prompt action as well as to prevent drug resistance toward standard breast cancer medications. Ferrite nanoparticles (NPs) are increasingly gaining momentum for their application in the diagnosis and treatment of breast cancer.

View Article and Find Full Text PDF

Background: Numerous reviews of the epidemiology and risk factors for breast cancer have been published previously which heighted different directions of breast cancer.

Aim: The present review examined the likelihood that incidence, prevalence, and particular risk factors might vary by geographic region and possibly by food and cultural practices as well.

Methods: A systematic review (2017-2022) was conducted following Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines, reporting on epidemiological and risk factor reports from different world regions.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Amna Roheel"

  • - Amna Roheel's recent research primarily focuses on breast cancer, exploring innovative diagnostic and treatment approaches through the application of ferrite nanoparticles and examining global epidemiological trends related to the disease.
  • - In her 2024 article, she highlights the potential of ferrite nanoparticles as a promising alternative to conventional breast cancer therapies, which often come with significant adverse effects and risks of drug resistance.
  • - Her systematic review published in October 2023 investigates the variability of breast cancer incidence and prevalence across different geographic regions, emphasizing the influence of regional dietary and cultural practices on risk factors.